Call Toll Free
800-416-7114
Home
View Cart
Check Out
Member Login
Join
Today
Customer Service
Feature
Product
| Immune System | |
|
Beta Glucan Natural Cellular Defense Immune Lotion Colloidal Silver MSM |
|
| Oxygen - Ozone | |
|
OxyLift-OxyMune OxySil Homozon Colosan Colosan Caps OxyFlush |
|
| Cellfood | |
|
Cellfood Cellfood Silica Cellfood MultiVit Cellfood Diet CellfoodDNA/RNA Cellfood Oxy Gel |
|
| Minerals | |
|
OxyEarth Essential Elements |
|
| Enzymes | |
|
Vitalzym X VitalzymSEB Vitalzym Neprinol |
|
| Health Library | |
|
FloodwithOxygen Cellfood Book |
|
| Allergies | |
What Can I Do For My Immune System
How Does My Immune System Work ?
|
|
Beta Glucan |
|
|
|
|
|
|
Studies indicate that glucan produces and enhanced state of the host defense against bacterial infections
Experts Urge Steps to Stem Antibiotic Resistance
Health experts are calling for changes in antibiotic use to slow the spread of drug-resistant infections such as tuberculosis. Resistance emerges when antibiotics alter the bacterial setting, eliminating sensitive strains and giving a survival advantage to germs that can endure the drug. Therefore, each time an antibiotic is used, the risk that a patient will become infected with, or become a carrier of, a resistant organism increases.
A recent study conducted by the federal Centers for disease Control and prevention found that more than one-third of the 150 million antibiotic prescriptions written annually for Americans who are not hospitalized was unnecessary. however, research has shown that changing how the drugs are used could have a substantial impact in reducing resistance. for example, a focus on directly observed therapy in which patients take their medicine in the presence of health care professionals helped to affect an 80 percent drop in new cases of multi-drug resistant TB in New York between 1992 and 1996. Paula I. Fujiwara, head of TB control in New York City's health department, noted, " You have to have a program in place to monitor, to give the drugs correctly, in order to prevent them being wasted." "Fluconazole-Resistant C. Albicans May Be Transmitted Orally" Reuters Health Information Services (8/25/97)
New research published in the July 15 issue of AIDS suggests that Candida albicans may be
transmitted between HIV-positive sexual partners, an event that would explain the
increased rate of gluconazole-resistant strains of C. albicans. Dr. Francoise Dromer
and colleagues at the Pasteur Institute investigated the oral flora of ten couples with
HIV and found that the "genetic diversity of the clones with one DNA subtype was
specific to a given patient or a given couple." the team also noted that
fluconazole-resistant strains were present in three individuals who had never received
azole treatment. "The fact that the couples tended to share genetically
indistinguishable clones [is] highly suggestive of transmission between partners,"
the scientists stated. The following are a series of one line quotes from the
scientific literature. Cites may be obtained off Medline.
The emergence of multiple antibiotic-resistant microorganisms has led to a search for
alternatives to traditional therapeutic regimens. Beta Glucan, and immunomodulator.,
can selectively enhance the microbicidal activities of neutrophils and macrophages without
stimulating pro-inflammatory cytokine production. Glucan is a potent
reticuloendothelial-modulating agent whose immunobiological activity is mediated in part
by an increase in the number and function of macrophages. Lysozyme concentration
were increased approximately sevenfold in some studies. Biologic response modifiers,
life Beta Glucan, will modulate immunity, modify neoplastic (cancer) disease and increase
resistance to microbial challenge. Glucan can enhance some elements of the immune
system against staphylococcal infections. Beta Glucan has been found to protect
against infection with Babesia microti, and intra-erythrocytic protozoan parasite,
nonspecific protection. Glucan has been shown to significantly inhibit renal
necrosis associated with systemic staphylococcal diseases and showed enhanced survival.
Glucan has been shown to increase peripheral leukocyte counts. Beta Glucan
induced increase in phagocytosis and induced hyperplasia of macrophages. Glucan
significantly enhanced survival when challenged systemically with Staphylococcus aureus.
These studies indicate that glucan confers and enhanced state of the host defense against bacterial infections. With orally administered glucan, interleukin-2 was evaluated in treated animals and showed and increase. There was significant increase in polymorphonuclear leukocytes and peripheral monocyte number. A significant increase in number and in vitro candidacidal activity was also observed for alveolar (lung) macrophages. The resistance towards systemic infection with Candida albicans of Staphylococcus aureus increased, significantly reducing the growth of microorganisms in the kidneys of infected animals. Toxicological studies showed that glucan is highly tolerated. In the area of protective capacity in respiratory infection, Beta Glucan significantly increased rated of phagocytosis and killing of Staphylococcus aureus. Beta Glucan greatly increased numbers of macrophages in the lungs of glucan treated rats; the lungs of glucan-treated mice appeared normal and that glucan can enhance intrapulmonary bacterial killing. The ability of glucan was shown to increase the number of lung macrophages resulting in increased bacterial ingestion. Particulate glucan resulted in significant reductions in the growth of a syngeneic anaplastic mammary carcinoma and melanoma and showed enhance survival. Studies demonstrate that prophylaxis with Beta Glucan in combination with antibiotics provided enhance protection against lethal challenge with Esherichia coli or Staphylococcus aureus as compares with the use of antibiotics alone.
